Average Co-Inventor Count = 11.51
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (8 from 3,685 patents)
2. Janssen Pharmaceutica Nv (1 from 2,079 patents)
8 patents:
1. 12378246 - Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
2. 11919863 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
3. 11649226 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl- D3)pyridazine-3-carboxamide
4. 11236048 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
5. 10899745 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
6. 8278462 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
7. 7705033 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
8. 7420079 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof